ORGO supply chain intelligence for Organogenesis Holdings Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Organogenesis Holdings Inc. (ORGO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| VIVEX-BIOLOGICS-INC | VIVEX-BIOLOGICS-INC | 92% | The Company paid an upfront licensing fee to Vivex to sell Dual and Matrix, and also agreed to pay a fixed milestone payment for Dual in the event that its average sales price ('ASP') is published by… |
| ALAN-ADES | ALAN-ADES | 90% | certain holders of 5% or more of the Company’s outstanding Class A common stock, par value $0.0001 per share (Alan Ades, Albert Erani, Dennis Erani and Glenn Nussdorf), directly or indirectly through… |
| ALBERT-ERANI | ALBERT-ERANI | 90% | certain holders of 5% or more of the Company’s outstanding Class A common stock, par value $0.0001 per share (Alan Ades, Albert Erani, Dennis Erani and Glenn Nussdorf), directly or indirectly through… |
| DENNIS-ERANI | DENNIS-ERANI | 90% | certain holders of 5% or more of the Company’s outstanding Class A common stock, par value $0.0001 per share (Alan Ades, Albert Erani, Dennis Erani and Glenn Nussdorf), directly or indirectly through… |
| GLENN-NUSSDORF | GLENN-NUSSDORF | 90% | certain holders of 5% or more of the Company’s outstanding Class A common stock, par value $0.0001 per share (Alan Ades, Albert Erani, Dennis Erani and Glenn Nussdorf), directly or indirectly through… |
| CELU | Celularity Inc. | 72% | Reciprocal relationship from CELU graph: . Our pipeline reflects our intent to leverage the unique biology of the placenta to develop placental-derived allogeneic cells for indications where the demo… |
| IART | Integra LifeSciences Holdings Corporation | 72% | Reciprocal relationship from IART graph: Reciprocal relationship from ORGO graph: Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufactur… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $116,860 across 9 awards. SPE2D625F87GE 4567338731!PURAPLY SX 6CM X 9CM; SPE2D625F2XPG 4569373821!PURAPLY SX 6CM X 9CM; SPE2D625F0RYG 4569054098!PURAPLY… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $11,880 across 1 awards. 36C26125P0849 PROSTHETICS - SPINAL SURGICAL IMPLANT/WOUND MATRIX | Qwen corrected direction: Explicit government contr… |
| KUWAIT | KUWAIT | 90% | Our Apligraf product is currently distributed by our direct sales force in Switzerland, and through independent sales agents in Saudi Arabia and Kuwait. |
| SAUDI-ARABIA | SAUDI-ARABIA | 90% | Our Apligraf product is currently distributed by our direct sales force in Switzerland, and through independent sales agents in Saudi Arabia and Kuwait. |
| SWITZERLAND | SWITZERLAND | 90% | Our Apligraf product is currently distributed by our direct sales force in Switzerland, and through independent sales agents in Saudi Arabia and Kuwait. |
| MEXICO | MEXICO | 80% | We have obtained marketing registration for our Dermagraft product in Mexico, but we are not currently distributing it. |
| IART | Integra LifeSciences Holdings Corporation | 72% | Reciprocal relationship from IART graph: rganization, our innovative technologies, and our procurement and manufacturing operations to maintain our competitive position. Our competitors for TT includ… |
| EUROPEAN-UNION | EUROPEAN-UNION | 70% | Additionally, we are evaluating the regulatory pathways and market potential for our products in other major markets, including the European Union. |
| NOVARTIS-PHARMA-AG | NOVARTIS-PHARMA-AG | 62% | ies encompasses, but is not limited to, direct-to-consumer advertising, healthcare provider-directed advertising and promotion, sales representative communications to healthcare professionals, promot… |
| PRESENTATION-ORGANOGENESIS-HOLDINGS-INC | PRESENTATION-ORGANOGENESIS-HOLDINGS-INC | 62% | ase obligations $ 483 $ — Landlord asset additions included in accounts payable and accrued expenses and other current liabilities, net of tenant allowances $ 4,067 $ — Right-of-use assets obtained t… |
| RESORBA-MEDICAL-GMBH | RESORBA-MEDICAL-GMBH | 62% | ies encompasses, but is not limited to, direct-to-consumer advertising, healthcare provider-directed advertising and promotion, sales representative communications to healthcare professionals, promot… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ORGO-DEBT | Debt stack $49.6M | 90% | Market cache reports total debt of $49.6M. |
| ORGO-DEBT-11582 | Warrants outstanding: 0 | 90% | xbrl warrant detail from xbrl 2019-12-31. |
| ORGO-DEBT-11583 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2018-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ORGO-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 90% | 13F overlay lists MORGAN STANLEY as top holder; 125 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 100.00 | 2 | |
| DTIL | Precision BioSciences, Inc. | 100.00 | 2 | |
| NTLA | Intellia Therapeutics, Inc. | 100.00 | 2 | |
| ALLO | Allogene Therapeutics, Inc. | 100.00 | 2 | |
| IART | Integra LifeSciences Holdings Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| ATRA | Atara Biotherapeutics, Inc. | 100.00 | 2 | |
| SGMO | Sangamo Therapeutics, Inc. | 100.00 | 2 | |
| IPSC | Century Therapeutics, Inc. | 100.00 | 2 | |
| KUWAIT | KUWAIT | 60.75 | 1 | ['receiving'] |
| SNNUF | Smith & Nephew plc | 50.00 | 2 | |
| MDT | Medtronic plc | 50.00 | 2 | |
| MDXG | MiMedx Group, Inc. | 50.00 | 2 | |
| SANM | Sanmina Corporation | 50.00 | 2 | |
| SMTI | Sanara MedTech Inc. | 50.00 | 2 | |
| SNN | Smith & Nephew plc | 50.00 | 2 | |
| SOR | Source Capital | 50.00 | 2 | |
| GLGI | Greystone Logistics, Inc. | 50.00 | 2 | |
| PLTR | Palantir Technologies Inc. | 50.00 | 2 | |
| PPC | Pilgrim's Pride Corporation | 50.00 | 2 | |
| WFRD | Weatherford International plc | 50.00 | 2 |